BG
ARIA

BlackRock Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.06M Buy
166,008
+8,218
+5% +$99K ﹤0.01% 1749
2016
Q3 		$2.16M Sell
157,790
-5,737
-4% -$57.6K ﹤0.01% 1569
2016
Q2 		$1.21M Sell
163,527
-8,075
-5% -$60.6K ﹤0.01% 1872
2016
Q1 		$1.1M Buy
171,602
+19,123
+13% +$107K ﹤0.01% 1895
2015
Q4 		$953K Sell
152,479
-2,469
-2% -$16.2K ﹤0.01% 1932
2015
Q3 		$904K Sell
154,948
-37,061
-19% -$286K ﹤0.01% 1945
2015
Q2 		$1.59M Buy
192,009
+22,666
+13% +$200K ﹤0.01% 1690
2015
Q1 		$1.4M Buy
169,343
+48,347
+40% +$357K ﹤0.01% 1673
2014
Q4 		$831K Buy
120,996
+23,652
+24% +$148K ﹤0.01% 1995
2014
Q3 		$525K Buy
97,344
+22,079
+29% +$129K ﹤0.01% 2151
2014
Q2 		$479K Sell
75,265
-69,155
-48% -$476K ﹤0.01% 2220
2014
Q1 		$1.17M Buy
144,420
+23,892
+20% +$186K ﹤0.01% 1916
2013
Q4 		$822K Sell
120,528
-468,130
-80% -$2.53M ﹤0.01% 2058
2013
Q3 		$10.8M Buy
588,658
+417,330
+244% +$8.1M 0.01% 909
2013
Q2 		$3M Buy
+171,328
New +$3.04M ﹤0.01% 1126

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Group's ARIA Position: Q4 2016 in Review

BlackRock Group increased its Ariad Pharmaceuticals Inc (ARIA) stake by 5.2% in Q4 2016, buying an estimated $99K and bringing the position to 166,008 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

BlackRock Group first reported a position in ARIA in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.8M in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • BlackRock Group held 166,008 shares of Ariad Pharmaceuticals Inc worth $2.06M as of Q4 2016.
  • BlackRock Group bought 8,218 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $99K.
  • Ariad Pharmaceuticals Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1749 holding.
  • BlackRock Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Ariad Pharmaceuticals Inc position peaked at $10.8M in Q3 2013.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.